AUTHOR=Valore Luca , Junker Till , Heilmann Eva , Zuern Christine S. , Streif Matthias , Drexler Beatrice , Arranto Christian , Halter Jörg P. , Berger Christoph T. TITLE=Case report: mRNA-1273 COVID-19 vaccine-associated myopericarditis: Successful treatment and re-exposure with colchicine JOURNAL=Frontiers in Cardiovascular Medicine VOLUME=10 YEAR=2023 URL=https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2023.1135848 DOI=10.3389/fcvm.2023.1135848 ISSN=2297-055X ABSTRACT=Introduction

Vaccine-induced myocarditis is a rare complication of messenger RNA (mRNA) COVID-19 vaccines.

Case presentation

We report a case of acute myopericarditis in a recipient of allogeneic hematopoietic cells following the first dose of the mRNA-1273 vaccine and the successful administration of a second and third dose while on prophylactic treatment with colchicine to successfully complete the vaccination.

Conclusion

Treatment and prevention of mRNA-vaccine-induced myopericarditis represent a clinical challenge. The use of colchicine is feasible and safe to potentially reduce the risk of this rare but severe complication and allows re-exposure to an mRNA vaccine.